Emerging antimicrobial resistance and newer tools to address the resistance

Goyal, Prashant; Semwal, Ankita; Prakash, Ajay; Medhi, Bikash

doi:10.4103/ijp.ijp_607_19

Cited by 5 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As an additional tool to track AMR, the pharmacovigilance systems 23 already existing in many countries could play a crucial role in settings where laboratory capacity for causality confirmation is still in its development stages. By using existing PV systems to generate real‐time and possibly geo‐tagged data on suspected or potential resistance to antimicrobials, PV systems will have an added function on top of their safety signals detection role.…”

Section: Discussionmentioning

confidence: 99%

Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance

Habarugira

Figueras

2021

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

Background: The WHO Programme for International Drug Monitoring (PIDM) is a large Pharmacovigilance network of countries sharing Adverse Drug Reaction (ADR) reports. Pharmacovigilance Experts have suggested that antimicrobial resistance (AMR) is an overlooked adverse event. We undertook this study to investigate the potential role of Pharmacovigilance databases in the surveillance of AMR. Methods: Using the AWaRe (Access, Watch and Reserve) list and the WHO Priority Pathogens List, we established a list of antimicrobials and carried out a VigiBase search via VigiAccess, looking for ADR reports with Preferred Terms (PTs) that contained AMR-relevant information. Identified Terms were matched with codes from the Medical Dictionary for Regulatory Activities (MedDRA Version 21.1).

show abstract

Section: Discussionmentioning

confidence: 99%

Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance

Habarugira

Figueras

2021

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

Routine immunization against Streptococcus pneumoniae and Haemophilus influenzae type B and antibiotic consumption in India: a dynamic modeling analysis

Kumar,

Gleason,

Parameswaran

et al. 2024

The Lancet Regional Health - Southeast Asia

View full text Add to dashboard Cite

Antimicrobial Resistance, Evidences on Irrational Anti-microbial Prescribing and Consumption during COVID-19 Pandemic and Possible Mitigation Strategies: A Bangladesh Perspective

Parveen

Yeasmin²,

Mma³

2020

Preprint

View full text Add to dashboard Cite

There are evidences that show increased antimicrobial consumption among COVID 19 patients. This has increased the burden on worsening situation of antimicrobial resistance (AMR) throughout the world. Bangladesh, one of the countries with highest numbers of COVID 19 cases, without effective regulation of antimicrobial prescription may suffer in future with study results showing a significant proportion of participants taking antimicrobial without proper indication and prescription from physicians. Suggested mitigation strategies include strict regulation of over the counter (OTC) antimicrobial prescription, testing biochemical marker such as procalcitonin prior to initiation of antimicrobial therapy, introduction of color coded and tightly sealed bottled antimicrobial drugs, massive campaigning on social media, effective utilization of telemedicine and finally, raising awareness among physicians and patients regarding judicial use of antimicrobial.

show abstract

Emerging antimicrobial resistance and newer tools to address the resistance

Cited by 5 publications

References 14 publications

Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance

Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance

Routine immunization against Streptococcus pneumoniae and Haemophilus influenzae type B and antibiotic consumption in India: a dynamic modeling analysis

Antimicrobial Resistance, Evidences on Irrational Anti-microbial Prescribing and Consumption during COVID-19 Pandemic and Possible Mitigation Strategies: A Bangladesh Perspective

Contact Info

Product

Resources

About